Testosterone ads spread the word about low testosterone, or low T. And to some, low T is an invented disease. In an editorial recently published in the Journal of the…
Read More
On March 3, 2015, the Food and Drug Administration began requiring drug makers to caution patients that testosterone medications may escalate the risk of heart attacks and strokes. The FDA…
Read More
Testosterone therapy promises men more energy and heightened libidos, but some patients say those promises were accompanied by heart attacks and pulmonary embolisms. Testosterone has been approved for men impacted…
Read More
St. Louis, Missouri (PRWEB) November 25, 2014 As a personal injury law firm with a focus on defective drug law, Carey Danis & Lowe have remained abreast of the news…
Read More
How can you make the right decision without proper direction? Many women have asked themselves that question after their life-changing experiences using Yaz, Yasmin, or Ocella. These women suffered serious…
Read More
August 15, 2009 – Boehringer Ingelheim researchers submitted Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial data to The New England Journal of Medicine October 19, 2010 – Pradaxa approved…
Read More
The NuvaRing mass tort in New Jersey recently convened on June 19, 2013 for a case management conference amid news that the first NuvaRing lawsuit consolidated into the mass tort…
Read More
According to a recent Madison-St. Clair Record article, NuvaRing lawsuits have recently been filed in the U.S. District Court for the Southern District of Illinois charging five defendants, among them…
Read More
A recent study led by Harvard researchers didn’t show meaningful improvement in men with low testosterone. Results from the study beg the question “Why are men with low testosterone being…
Read More
The Yaz and Yasmin multidistrict litigation (MDL) in the U.S. District Court for the Southern District of Illinois continues to progress, according to Carey Danis & Lowe Yaz and Yasmin…
Read More